Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas

Oncology Reports

Volumn 18, Issue 1, 2007, Pages 267-272

  Park, Hun Woong ^a   Song, Si Youn ^a   Lee, Tae Jin ^a   Jeong, Daewon ^a   Lee, Tae Yoon ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Alteration; Cyclin D1; Head and neck squamous cell carcinoma; p16; Retinoblastoma

Indexed keywords

CYCLIN D; CYCLINE; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CULTURE; CHROMOSOME 9; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HETEROZYGOSITY LOSS; HUMAN; KOREA; METABOLISM; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLINS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; KOREA; LOSS OF HETEROZYGOSITY; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 34548050461     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Stewart BW and Kleihues P: WHO World Cancer Report. International Agency for Research on Cancer, Geneva, pp232-236, 2003.
2. Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA Cancer J Clin 49: 33-64, 1999. (Pubitemid 29094960)
3. Dobrossy L: Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 24: 9-17, 2005.
4. Saranath D, Bhoite LT and Deo MG. Molecular lesions in human oral cancers: the Indian scene. Oral Oncol 29B: 107-112, 1993. (Pubitemid 23156614)
5. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnick MH: A cell-cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994.
6. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
7. Motokura T and Arnold A: Cyclins and oncogenesis. Biochim Biophys Acta 1155: 63-78, 1993. (Pubitemid 23163751)
8. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B and Bartek J: Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55: 949-956, 1995.
9. Maelandsmo GM, Florenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Borresen AL and Fodstad O: Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Br J Cancer 73: 909-916, 1996. (Pubitemid 26116742)
10. Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R and Weinstein IB: Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90: 9026-9030, 1993. (Pubitemid 23306444)
11. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM and Arnold A: A novel cyclin encoded by a bcl-linked candidate oncogene. Nature 350: 512-515, 1991. (Pubitemid 21912266)
12. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E and Levine PA: Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 119: 1238-1243, 1993. (Pubitemid 23339141)
13. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J and Cardesa A: PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 54: 4813-4817, 1994.
14. El-Naggar AK, Steck K and Batsakis JG: Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. Cytometry 21: 47-51, 1995.
15. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756, 1994. (Pubitemid 24153417)
16. Mori T, Miura K, Aoki T, Nishihira T, Mori S and Nakamura Y: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397, 1994. (Pubitemid 24225957)
17. INK4 in human cancer. Proc Natl Acad Sci USA 91: 11045-11049, 1994.
18. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D and Sidransky D: Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat Genet 11: 210-212, 1995.
19. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J and Bartek J: The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 56: 5475-5483, 1996. (Pubitemid 27011383)
20. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J and Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56: 3630-3633, 1996. (Pubitemid 26272001)
21. Weber A, Langhanki L, Schutz A, Wittekind C, Bootz F and Tannapfel A: Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. J Pathol 198: 326-334, 2002. (Pubitemid 35277383)
22. Lydiatt WM, Murty VV, Davidson BJ, Xu L, Dyomina K, Sacks PG, Schantz SP and Chaganti RS: Homozygous deletions and loss of expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors. Genes Chromosomes Cancer 13: 94-98, 1995.
23. Gruttgen A, Reichenzeller M, Junger M, Schlien S, Affolter A and Bosch FX: Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers. J Pathol 194: 311-317, 2001. (Pubitemid 32624557)
24. Gonzalez MV, Pello MF, Lopez-Larrea C, Suarez C, Menendez MJ and Coto E: Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck. Clin Cancer Res 1: 1043-1049, 1995.
25. Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM and Weinstein IB: Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196: 1010-1016, 1993. (Pubitemid 23337708)
26. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE and Sidransky D: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265: 415-417, 1994. (Pubitemid 24259979)
27. Poi MJ, Yen T, Li J, Song H, Lang JC, Schuller DE, Pearl DK, Casto BC, Tsai MD and Weghorst CM: Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck. Mol Carcinog 30: 26-36, 2001. (Pubitemid 32127347)
28. Tripathi A, Banerjee S, Roy A, Roychowdhury S and Panda CK: Alterations of the P16 gene in uterine cervical carcinoma from Indian patients. Int J Gynecol Cancer 13: 472-479, 2003. (Pubitemid 38220665)
29. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
30. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D and Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812-1817, 1994. (Pubitemid 24116192)
31. Naitoh H, Shibata J, Kawaguchi A, Kodama M and Hattori T: Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146: 1161-1169, 1995.
32. Parry D, Bates S, Mann DJ and Peters G: Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J 14: 503-511, 1995.
33. Schauer IE, Siriwardana S, Langan TA and Sclafani RA: Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc Natl Acad Sci USA 91: 7827-7831, 1994. (Pubitemid 24238278)